Therapeutics Delivery for Neurodegenerative Diseases (R21)

The summary for the Therapeutics Delivery for Neurodegenerative Diseases (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Therapeutics Delivery for Neurodegenerative Diseases (R21): Purpose. The NIH Blueprint for Neuroscience Research is a framework to enhance cooperative activities among the NIH Office of the Director and 15 NIH Institutes and Centers that support research on the nervous system. By pooling resources and expertise, the Blueprint takes advantage of economies of scale, confronts challenges too large for any single Institute or Center, and develops research tools and infrastructure that serve the entire neuroscience community. In FY 2007, the Blueprint is focusing on neurodegeneration. Mechanism of Support. This funding opportunity will utilize the Exploratory/Developmental (R21) to solicit grant applications from applicant organizations that propose to develop biomarkers of neurodegenerative disease. Funds Available and Anticipated Number of Awards. The participating organizations intend to commit a total of $2,750,000 to this RFA for payment of applications responsive to this announcement. The anticipated number of awards is 12-14. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Therapeutics Delivery for Neurodegenerative Diseases (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Income Security and Social Services Environment Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-EY-07-001
Type of Funding: Grant
CFDA Numbers: 93.12193.173
CFDA Descriptions: Oral Diseases and Disorders Research 93.173 Research Related to Deafness and Communication Disorders
Current Application Deadline: No deadline provided
Original Application Deadline: Dec 09, 2006
Posted Date: Oct 02, 2006
Creation Date: Oct 02, 2006
Archive Date: Jan 08, 2007
Total Program Funding: $2,750,000
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.213 -- Research and Training in Complementary and Alternative Medicine
Applicants Eligible for this Grant
Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal governments (Federally recognized) Independent school districts Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Private institutions of higher education County governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Applicants may submit more than one application, provided each application is scientifically distinct.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster